Table 2.

Treatment of bleeding in AH

Treatment of bleeding in AH

* A dose of 50 U/kg is expected to increase factor VIII level by 100% in a noninhibitor patient.

† The package insert suggests an initial dose of 200 U/kg. Response depends on underlying cross reactivity of inhibitors and a significantly reduced dose of 100 U/kg is likely sufficient.

‡ There are no FDA approved dosing recommendations for FEIBA for AH, a usual dose is 40-75 U/kg.

Close Modal

or Create an Account

Close Modal
Close Modal